Pacific Edge (NZ: PEB)

Last close As at 12/06/2024

1.23

−0.01 (−0.81%)

Market capitalisation

896m

Edison Investment Research is terminating coverage on Pacific Edge. Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Previously published reports can still be accessed via our website.

Latest Insights

View More

Healthcare | Update

Pacific Edge — Operating revenue up 46% on strong US growth

Healthcare | Update

Pacific Edge — CMS reimbursement obtained

Healthcare | Outlook

Pacific Edge — CMS coverage pending

Healthcare | Update

Pacific Edge — 2019 finishes strongly

Share Price Performance

Financials

Edison Investment Research is terminating coverage on Pacific Edge. Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Previously published reports can still be accessed via our website.

Research

Update

Healthcare

Pacific Edge — 2019 finishes strongly

Update

Healthcare

Pacific Edge — Test sales up 43% in H119

Outlook

Healthcare

Pacific Edge — Anticipating commercial growth

Update

Healthcare

Pacific Edge — A growth year

Update

Healthcare

Pacific Edge — Update 13 February 2017

Outlook

Healthcare

Pacific Edge — Update 26 June 2016

Update

Healthcare

Pacific Edge — Update 16 November 2015

Thematics

thematic

Healthcare

Deutsches Eigenkapitalforum (EKF) 2023 healthcare

volition01

thematic

Healthcare

VolitionRx – Decoding the DNA of cancer 

thematic

Healthcare

ASCO 2023 key takeaways

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free